Ici 118551 hydrochloride
CAS: 72795-19-8
Ref. 3D-XCA79519
1mg | 172,00 € | ||
5mg | 480,00 € | ||
10mg | 711,00 € | ||
25mg | 1.449,00 € | ||
50mg | 2.609,00 € |
Información del producto
- (2R,3S)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]butan-2-ol
- (R*,S*)-(±)-1-[(2,3-Dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol
- 1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-(propan-2-ylamino)butan-2-ol hydrochloride (1:1)
- 2-Butanol, 1-[(2,3-dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-, (2R,3S)-rel-
- 2-Butanol, 1-[(2,3-dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-, (R*,S*)-
- Ci 118,551
- ICI-118551 HCl
- Ici-118551
- rel-(2R,3S)-1-[(2,3-Dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol
Ici 118551 is a low potency, non-steroidal, androgen receptor antagonist. It has been shown to inhibit the proliferation of human prostate cancer cells by binding to the androgen receptor. Ici 118551 also inhibits cardiac hypertrophy in rats, which may be due to its ability to block the effects of angiotensin II. The drug also blocks the effects of 2-adrenergic receptors in the heart muscle and papillary muscles, reducing cytosolic Ca2+ levels. Ici 118551 also has a strong effect on Toll-like receptor 4 (TLR4) signalling pathways in mouse models of sepsis, which may be due to its ability to reduce proinflammatory cytokines (IL-1β) and prevent activation of NF-κB.
Propiedades químicas
Consulta técnica sobre: 3D-XCA79519 Ici 118551 hydrochloride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.